BRD2 and endometrial cancer: In the context of higher circulating lipids in EC disease state, metabolic syndrome as a risk factor for EC, and the evidence for raised lipid profiles and FSH in post-menopausal women, understanding the mechanism by which FSH causes these effects, and the role for FSH-induced LDs in endometrial cancer cells is highly pertinent and a subject of future research.